Search details
1.
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.
Cell
; 173(7): 1770-1782.e14, 2018 06 14.
Article
in English
| MEDLINE | ID: mdl-29906450
2.
Integrative clinical genomics of advanced prostate cancer.
Cell
; 161(5): 1215-1228, 2015 May 21.
Article
in English
| MEDLINE | ID: mdl-26000489
3.
Integrative Clinical Genomics of Advanced Prostate Cancer.
Cell
; 162(2): 454, 2015 Jul 16.
Article
in English
| MEDLINE | ID: mdl-28843286
4.
Racial differences in serum chemokines in prostate cancer patients.
Cancer
; 129(23): 3783-3789, 2023 12 01.
Article
in English
| MEDLINE | ID: mdl-37698493
5.
Nested and Large Nested Subtypes of Urothelial Carcinoma of the Upper Urinary Tract: A Multi-institutional Study.
Mod Pathol
; 36(12): 100333, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37717923
6.
Clear cell renal cell carcinoma with focal psammomatous calcifications: a rare occurrence mimicking translocation carcinoma.
Histopathology
; 82(5): 684-690, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36564980
7.
Integrative clinical genomics of metastatic cancer.
Nature
; 548(7667): 297-303, 2017 08 17.
Article
in English
| MEDLINE | ID: mdl-28783718
8.
Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients.
Mod Pathol
; 35(6): 836-849, 2022 06.
Article
in English
| MEDLINE | ID: mdl-34949766
9.
Genomic correlates of clinical outcome in advanced prostate cancer.
Proc Natl Acad Sci U S A
; 116(23): 11428-11436, 2019 06 04.
Article
in English
| MEDLINE | ID: mdl-31061129
10.
Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach.
J Urol
; 205(3): 732-739, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33080150
11.
Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer.
Mol Cell
; 49(1): 80-93, 2013 Jan 10.
Article
in English
| MEDLINE | ID: mdl-23159737
12.
Reply to "Contextualizing racial associations in prostate cancer to expose structural causes".
Cancer
; 130(4): 647-648, 2024 02 15.
Article
in English
| MEDLINE | ID: mdl-38079361
13.
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
N Engl J Med
; 373(18): 1697-708, 2015 Oct 29.
Article
in English
| MEDLINE | ID: mdl-26510020
14.
The mutational landscape of lethal castration-resistant prostate cancer.
Nature
; 487(7406): 239-43, 2012 Jul 12.
Article
in English
| MEDLINE | ID: mdl-22722839
15.
Expression and Role of PAICS, a De Novo Purine Biosynthetic Gene in Prostate Cancer.
Prostate
; 77(1): 10-21, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27550065
16.
Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk Stratification Algorithm Based on Biopsy and Mass Size for Assigning Surveillance versus Treatment of Renal Tumors.
J Urol
; 195(3): 574-80, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26523883
17.
Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and Recurrence.
J Urol
; 196(2): 405-11, 2016 08.
Article
in English
| MEDLINE | ID: mdl-26920466
18.
Independent surgical validation of the new prostate cancer grade-grouping system.
BJU Int
; 118(5): 763-769, 2016 Nov.
Article
in English
| MEDLINE | ID: mdl-27009882
19.
Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India.
Prostate
; 75(10): 1051-62, 2015 Jul 01.
Article
in English
| MEDLINE | ID: mdl-25809148
20.
Metastases to the kidney: a clinicopathological study of 43 cases with an emphasis on deceptive features.
Histopathology
; 66(4): 587-97, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25406592